Cell Therapy Trial Targets Type 1 Diabetes In Children
August 8, 2017Clinical Leader's Chief Editor, Ed Miseta, on Caladrius' type 1 diabetes product candidate, CLBS03, progress through its phase 2 clinical trial.
Clinical Leader’s Chief Editor, Ed Miseta, on Caladrius’ type 1 diabetes product candidate, CLBS03, progress through its phase 2 clinical trial. Click here to read the article.